BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36033622)

  • 1. Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer's disease risk.
    Ma J; Qiu S
    Front Neurosci; 2022; 16():926830. PubMed ID: 36033622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between CLU gene rs11136000 polymorphism and Alzheimer's disease: an updated meta-analysis.
    Zhu R; Liu X; He Z
    Neurol Sci; 2018 Apr; 39(4):679-689. PubMed ID: 29396813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CLU gene rs11136000 variant is significantly associated with Alzheimer's disease in Caucasian and Asian populations.
    Liu G; Wang H; Liu J; Li J; Li H; Ma G; Jiang Y; Chen Z; Zhao B; Li K
    Neuromolecular Med; 2014 Mar; 16(1):52-60. PubMed ID: 23892938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing 74,248 Samples Confirms the Association Between CLU rs11136000 Polymorphism and Alzheimer's Disease in Caucasian But Not Chinese population.
    Han Z; Qu J; Zhao J; Zou X
    Sci Rep; 2018 Jul; 8(1):11062. PubMed ID: 30038359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between clusterin gene polymorphism rs11136000 and late-onset Alzheimer's disease susceptibility: A review and meta-analysis of case-control studies.
    Du W; Tan J; Xu W; Chen J; Wang L
    Exp Ther Med; 2016 Nov; 12(5):2915-2927. PubMed ID: 27882096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Link of
    Abdul Aziz M; Md Ashraf G; Safiqul Islam M
    Curr Alzheimer Res; 2022; 19(4):302-316. PubMed ID: 35546756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informative combination of CLU rs11136000, serum HDL levels, diabetes, and age as a new piece of puzzle-picture of predictive medicine for cognitive disorders.
    Aghajanpour-Mir M; Amjadi-Moheb F; Dadkhah T; Hosseini SR; Ghadami E; Assadollahi E; Akhavan-Niaki H; Ahmadi Ahangar A
    Mol Biol Rep; 2019 Feb; 46(1):1033-1041. PubMed ID: 30560405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of clusterin gene (CLU/APOJ) polymorphism in Alzheimer's disease patients and in normal cohorts from Russian populations].
    Golenkina SA; Gol'tsov AIu; Kuznetsova IL; Grigorenko AP; Andreeva TV; Reshetov DA; Kunizheva SS; Shagam LI; Morozova IIu; Goldenkova-Pavlova IV; Shimshilashvili Kh; Viacheslavova AO; Faskhutdinova G; Gareeva AÉ; Zaĭnullina AG; Khusnutdinova ÉK; Puzyrev VP; Stepanov VA; Kolotvin AV; Samokhodskaia LM; Selezneva ND; Gavrilova SI; Rogaev EI
    Mol Biol (Mosk); 2010; 44(4):620-6. PubMed ID: 20873220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease risk variant in CLU is associated with neural inefficiency in healthy individuals.
    Lancaster TM; Brindley LM; Tansey KE; Sims RC; Mantripragada K; Owen MJ; Williams J; Linden DE
    Alzheimers Dement; 2015 Oct; 11(10):1144-52. PubMed ID: 25496871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.
    Zhou Y; Hayashi I; Wong J; Tugusheva K; Renger JJ; Zerbinatti C
    PLoS One; 2014; 9(7):e103187. PubMed ID: 25051234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.
    Roussotte FF; Gutman BA; Madsen SK; Colby JB; Thompson PM;
    J Neurosci; 2014 May; 34(19):6537-45. PubMed ID: 24806679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer's Disease in a Central European Population.
    Balcar VJ; Zeman T; Janout V; Janoutová J; Lochman J; Šerý O
    Neurochem Res; 2021 Feb; 46(2):411-422. PubMed ID: 33206315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LACK OF ASSOCIATIONS BETWEEN CLU AND PICALM GENE POLYMORPHISMS AND ALZHEIMER'S DISEASE IN A TURKISH POPULATION.
    Sen A; Arslan M; Erdal ME; Ay OI; Yilmaz SG; Kurt E; Arpaci B
    Ideggyogy Sz; 2015 Mar; 68(3-4):113-20. PubMed ID: 26434199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between CLU polymorphisms and memory performance: The role of serum lipids in Alzheimer's disease.
    Chen LH; Heng Mak TS; Fan Y; Yin Ho DT; Sham PC; Chu LW; Song YQ
    J Psychiatr Res; 2020 Oct; 129():281-288. PubMed ID: 32882505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity factor contributes to altered brain functional networks in individuals at risk for Alzheimer's disease: Neuroimaging-genetic evidence.
    Bai F; Shi Y; Yuan Y; Xie C; Zhang Z
    Brain Behav Immun; 2016 Aug; 56():84-95. PubMed ID: 26899953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Tan L; Wang HF; Tan MS; Tan CC; Zhu XC; Miao D; Yu WJ; Jiang T; Tan L; Yu JT;
    Sci Rep; 2016 May; 6():26027. PubMed ID: 27229352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer's disease.
    Mullan GM; McEneny J; Fuchs M; McMaster C; Todd S; McGuinness B; Henry M; Passmore AP; Young IS; Johnston JA
    Curr Alzheimer Res; 2013 Nov; 10(9):973-8. PubMed ID: 24117116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.
    Cai R; Han J; Sun J; Huang R; Tian S; Shen Y; Dong X; Xia W; Wang S
    Front Aging Neurosci; 2016; 8():179. PubMed ID: 27516739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals.
    Nordestgaard LT; Tybjærg-Hansen A; Rasmussen KL; Nordestgaard BG; Frikke-Schmidt R
    BMC Med; 2018 Mar; 16(1):39. PubMed ID: 29534716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
    Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
    Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.